Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.
Eung Gu LeeTae-Hee LeeYujin HongJiwon RyooJung Won HeoBo Mi GilHye Seon KangSoon Seog KwonYong Hyun KimPublished in: PloS one (2021)
Low-dose pirfenidone provided beneficial effects on survival and pulmonary function decline in the real-world practice.